Net profit of Metropolis Healthcare declined 24.13% to Rs 27.16 crore in the quarter ended December 2023 as against Rs 35.80 crore during the previous quarter ended December 2022. Sales rose 1.98% to Rs 291.12 crore in the quarter ended December 2023 as against Rs 285.46 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales291.12285.46 2 OPM %22.2724.69 - PBDT61.8571.00 -13 PBT36.8547.97 -23 NP27.1635.80 -24 Powered by Capital Market - Live News

Net profit of Metropolis Healthcare declined 18.67% to Rs 26.70 crore in the quarter ended December 2023 as against Rs 32.83 crore during the previous quarter ended December 2022. Sales rose 1.84% to Rs 269.41 crore in the quarter ended December 2023 as against Rs 264.55 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales269.41264.55 2 OPM %21.8324.76 - PBDT58.7766.33 -11 PBT34.6344.38 -22 NP26.7032.83 -19 Powered by Capital Market - Live News

Metropolis Healthcare will hold a meeting of the Board of Directors of the Company on 2 February 2024.Powered by Capital Market - Live News

Metropolis Healthcare announced that the Board of Directors of the Company at its meeting held on 4 November 2023, inter alia, have recommended the interim dividend of Rs 4 per equity Share (i.e. 200%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Metropolis Healthcare declined 12.10% to Rs 35.45 crore in the quarter ended September 2023 as against Rs 40.33 crore during the previous quarter ended September 2022. Sales rose 2.71% to Rs 308.50 crore in the quarter ended September 2023 as against Rs 300.35 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales308.50300.35 3 OPM %24.2526.31 - PBDT70.3576.38 -8 PBT48.1154.80 -12 NP35.4540.33 -12 Powered by Capital Market - Live News